Shopping Cart
Remove All
Your shopping cart is currently empty
BAY-6672 is a selective human prostaglandin F (FP) receptor antagonist that is highly potent (IC50=11 nM), orally available and well permeable. It exerts antifibrotic effects by inhibiting prostaglandin F2α (PGF₂α) activity through antagonizing the FP receptor, and has in vivo efficacy in animal models of idiopathic pulmonary fibrosis (IPF).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $196 | - | In Stock | |
| 5 mg | $498 | - | In Stock | |
| 10 mg | $725 | - | In Stock | |
| 25 mg | $1,130 | - | In Stock |
| Description | BAY-6672 is a selective human prostaglandin F (FP) receptor antagonist that is highly potent (IC50=11 nM), orally available and well permeable. It exerts antifibrotic effects by inhibiting prostaglandin F2α (PGF₂α) activity through antagonizing the FP receptor, and has in vivo efficacy in animal models of idiopathic pulmonary fibrosis (IPF). |
| In vivo | Methods: Anti-fibrotic activity of BAY-6672 (3, 10, 30 mg/kg, twice daily) in a 10-day silica-induced pulmonary fibrosis model in mice. Results: Significant reductions in relevant profibrotic and inflammatory biomarkers, including the cytokines IL-1 and MCP-1, and the ECM protein osteopontin (OPN), were observed.[1] |
| Synonyms | BAY6672 |
| Molecular Weight | 544.87 |
| Formula | C26H27BrClN3O3 |
| Cas No. | 2247517-53-7 |
| Smiles | C(NC[C@H](CCC(O)=O)C1=C(Cl)C=CC=C1)(=O)C=2C3=C(N=C(C2C)N4CCCC4)C=CC(Br)=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.